NanoString, now a Bruker business, will promptly seek an end to the injunction impacting sales of CosMx SMI products in Germany BILLERICA, Mass. — Bruker Corporation (Nasdaq: BRKR) today announced that the German Federal Patent Court has ruled in favor of NanoString Technologies Germany GmbH by invalidating European Patent No. 2794928B1 (the “928 Patent”) in Germany […]

U.S. District Court grants Vizgen motion to expand antitrust case against 10x and Harvard based on newly discovered evidence. CAMBRIDGE, Mass. — Vizgen, Inc., the life science company dedicated to improving human health by visualizing single-cell spatial genomics information, has achieved a significant victory in its ongoing legal battle with 10x Genomics and Harvard University.  […]

Court finds non-infringement by Curio Seeker with respect to over-reaching claim by 10x Genomics PALO ALTO, Calif. —-Curio Bioscience, a leading innovator of high-precision tools for the life sciences industry, today announced that a decision in a court case has been made. The European Unified Patent Court (UPC) today announced a finding that Curio Seeker […]

CAMBRIDGE, Mass. — Vizgen, Inc., the life science company dedicated to improving human health by visualizing single-cell spatial genomics information, announced today the issuance by the US Patent Office of a patent that covers the in situ imaging of the spatial transcriptome. U.S. Patent No. 11,959,075 is for robust multiplex imaging of RNA and its spatial organization […]

SAN DIEGO — Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced it has received approval of its divestment plan for GRAIL from the European Commission (EC). While this does not mean the method of divestment has been finalized, the company is pleased to reach an agreement with the EC […]

WALTHAM, Mass. — Today, Revvity, Inc. (NYSE: RVTY) announced that the Massachusetts Superior Court has granted a preliminary injunction compelling Cloud Software Group (CSG) to comply with its contractual obligations under its strategic partner agreements with Revvity, including an order to cease all marketing, selling and support activities in Revvity’s exclusive markets and to continue delivering […]

PALO ALTO, CA, UNITED STATES — Gator Bio is pleased to announce a complete victory before the U.S. International Trade Commission (ITC) resulting in an initial determination of “no violation” in a case related to biolayer interferometry (BLI) products. It prevailed on noninfringement and lack of technical domestic industry on multiple independent grounds. In June 2023, […]

Asserts CSG has acted in bad faith, ignoring obligations as strategic partner for Spotfire® software WALTHAM, Mass. —  Today, Revvity, Inc. (NYSE: RVTY) announced that it has filed a complaint against Cloud Software Group (CSG) in Massachusetts Superior Court and requested injunctive relief to enforce Revvity’s rights and CSG’s obligations as a strategic partner. CSG is refusing […]

CAMBRIDGE, Mass. – Vizgen, Inc., the life science company dedicated to improving human health by visualizing single-cell spatial genomics information, is very pleased to announce that, on March 7, 2024, the Patent Trial and Appeal Board (PTAB) of the United States Patent and Trademark Office (USPTO) denied 10x Genomics Inc.’s petition to institute an Inter Partes Review […]

Cambridge, Mass. – Vizgen, Inc., the life science company dedicated to improving human health by visualizing single-cell spatial genomics information, has announced a significant capital raise to fuel its continued growth and execution of long-term vision. At the same time, the company has also taken steps to streamline its operations and reduce headcount. These measures […]